Supplementation of Conventional Therapy With the Novel Grain Salba (Salvia hispanica L.) Improves Major and Emerging Cardiovascular Risk Factors in Type 2 Diabetes
Open Access
- 1 November 2007
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (11), 2804-2810
- https://doi.org/10.2337/dc07-1144
Abstract
OBJECTIVE—To determine whether addition of Salba (Salvia hispanica L.), a novel whole grain that is rich in fiber, α-linolenic acid (ALA), and minerals to conventional treatment is associated with improvement in major and emerging cardiovascular risk factors in individuals with type 2 diabetes.Keywords
This publication has 24 references indexed in Scilit:
- Purified Eicosapentaenoic Acid Reduces Small Dense LDL, Remnant Lipoprotein Particles, and C-Reactive Protein in Metabolic SyndromeDiabetes Care, 2007
- Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic reviewAtherosclerosis, 2006
- von Willebrand factor, endothelial dysfunction, and cardiovascular diseaseJournal of Thrombosis and Haemostasis, 2006
- Effect of linolenic acid on cardiovascular risk markers: a systematic reviewPublished by BMJ ,2006
- Whole grains and CVD riskProceedings of the Nutrition Society, 2006
- Increased α-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosisEuropean Journal of Clinical Nutrition, 2004
- Comparison of the effects of two low fat diets with different α-linolenic:linoleic acid ratios on coagulation and fibrinolysisAtherosclerosis, 1999
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of Internal Medicine, 1997
- Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitusJAMA, 1994
- The effects of dietary marine fish oils (omega-3 fatty acids) on coagulation profiles in menGeneral Pharmacology: The Vascular System, 1990